IL17RA and pancreatic neoplasm: The pivotal finding of the study elucidated that extra‐tumoral IL‐17RA deficiency or blockade unexpectedly elicited the secretion of IL‐17A in response to microbial stimuli, subsequently leading to the systemic elevation of IL‐17A levels and promoting the growth of pancreatic tumors.